AlphaVac System for Treating Acute Pulmonary Embolism
Part of Heart & circulation, Lungs & breathing clinical trials.
This study tests a device that suctions blood clots from the lungs in people with a moderate-risk pulmonary embolism. The goal is to see if it is safe and effective at removing clots and improving blood flow.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have symptoms of a pulmonary embolism that started within the last 14 days and it was confirmed by a CT scan.
- Your blood pressure is 90 mmHg or higher and your heart rate is 130 beats per minute or less before the procedure.
- You have a right-to-left heart ratio of 0.9 or higher on imaging.
- You are at least 18 years old and can give consent.
- You are not pregnant, not on certain blood thinners that can't be stopped, and have no recent major surgery or trauma.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device (the Akura Thrombectomy System) that removes blood clots from the lungs in people with a sudden, severe pulmonary embolism. It aims to see if the device is safe and effective at improving blood flow and heart function.
This trial tests a new device that removes blood clots from the lungs through a small tube. It is for people with a recent pulmonary embolism who have slightly strained hearts but stable blood pressure.
This trial tests a new system to remove blood clots from the lungs in people with acute pulmonary embolism (a sudden blockage in a lung artery). It may help those who are stable enough for a catheter-based procedure but still have significant strain on the heart.
This trial tests the Vibrato Aspiration System, a device that suctions blood clots from the lungs in people with a recent pulmonary embolism (PE). It aims to see if the procedure is safe and works well for removing clots.
This trial tests whether a standard procedure using a catheter to deliver clot-dissolving medicine directly into the lung artery works well for people with a serious but not immediately life-threatening blood clot in the lungs (pulmonary embolism). It aims to improve heart function and reduce long-term complications.
This study tests a new device (AlphaVac) that removes blood clots from the lungs using a thin tube inserted through a vein. It may be an option for people with acute pulmonary embolism who have signs of heart strain or low blood pressure.
Hear when a new Pulmonary Embolism Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.